LRP8 and Alzheimer disease: We found that early, pre‐symptomatic treatment of AD‐like mice with an ASO that increases ApoER2 exon 19 inclusion has no adverse effects on the animals and results in an improved performance at spatial learning tasks compared to mice treated with a control ASO.